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Origin recognition complex subunit 1 (ORC1) is essential for DNA replication in eukaryotes. The deadly
human malaria parasite Plasmodium falciparum contains an ORC1/CDC6 homolog with several interesting
domains at the catalytic carboxyl-terminal region that include a putative nucleoside triphosphate-binding and
hydrolysis domain, a putative PCNA-interacting-protein (PIP) motif, and an extreme C-terminal region that
shows poor homology with other ORC1 homologs. Due to the unavailability of a dependable inducible gene
expression system, it is difficult to study the structure and function of essential genes in Plasmodium. Using a
genetic yeast complementation system and biochemical experiments, here we show that the putative PIP
domain in ORC1 that facilitates in vitro physical interaction with PCNA is functional in both yeast (Saccha-
romyces cerevisiae) and Plasmodium in vivo, confirming its essential biological role in eukaryotes. Furthermore,
despite having less sequence homology, the extreme C-terminal region can be swapped between S. cerevisiae and
P. falciparum and it binds to DNA directly, suggesting a conserved role of this region in DNA replication. These
results not only provide us a useful system to study the function of the essential genes in Plasmodium, they help
us to identify the previously undiscovered unique features of replication proteins in general.
Origin recognition complex subunit 1 (ORC1), the largest
subunit among the ORC components is essential for DNA
replication initiation in eukaryotes. ORC1 has a regulatory
function in DNA replication since it comes on and off chro-
matin during cell cycle. Human ORC binds to chromatin dur-
ing G1 phase of the cell cycle, followed by degradation of
ORC1 by a ubiquitin-mediated pathway. ORC1 reappears dur-
ing M phase, and it binds to DNA at the onset of G1 phase
(21). In mammalian cells, monoubiquitination and phosphory-
lation may also lead to the subcellular localization of ORC1 to
control DNA replication (24). In the case of Xenopus laevis,
ORC1 is bound to chromatin during early interphase but it is
destabilized later with the loading of MCM proteins on chro-
matin (23). While in Drosophila melanogaster, the level of
ORC1 is developmentally regulated (2), the murine ORC1
binds to specific locus in the ribosomal RNA in a cell-cycle-
dependent manner (29). Interestingly, in the yeast Saccharomy-
ces cerevisiae, although ORC is tightly bound to chromatin
throughout the cell cycle, another pre-replication complex (pre-
RC) protein, CDC6, comes on and off chromatin, ensuring the
control of DNA replication during cell cycle (7, 22). The role of S.
cerevisiae ORC1 (ScORC1) in ORC-DNA binding and modulat-
ing ScORC function has been described recently using high-
resolution electron microscopy of ScORC (5).
ORC1 proteins consist of two highly conserved domains: the
N-terminal regulatory domain that contains the bromo-adja-
cent homology domain and the C-terminal catalytic domain
that contains the AAA ATPase domain. The bromo-adjacent
homology domain is involved in the regulation of gene expres-
sion through protein-protein interaction (4). It also facilitates
the binding of ORC1 to the replication origin (21). The AAA
ATPase domain that binds and hydrolyzes ATP is essential for
DNA replication in several organisms (11, 27).
Plasmodium falciparum, the causative agent of human ma-
laria, contains an ortholog of ORC1/CDC6, although there is
no separate CDC6 protein in Plasmodium. The homology of P.
falciparum ORC1 (PfORC1) with other ORC1 counterparts is
predominantly confined to the C-terminal region containing
the putative nucleoside triphosphate (NTP)-binding and hy-
drolysis domain (residues 784 to 1014) (see Fig. S1 in the
supplemental material). The N-terminal region (residues 1 to
783) and the extreme C-terminal region of PfORC1 (residues
1015 to 1189) exhibit poor homology with other ORC1 coun-
terparts (14, 17) (see Fig. S1 in the supplemental material).
The latter domain of PfORC1 (residues 1015 to 1189) may
have a unique role in DNA binding since the crystal structure
of archaeal (Aeropyrum pernix and Sulfolobus solfataricus)
ORC1/CDC6-like protein along with origin DNA suggests that
the extreme C-terminal region of this protein forms a wing-
helix domain that binds to DNA (6, 10). Similarly, another
member of the pre-RC, Cdc6, also contains a wing-helix do-
main at the extreme C terminus (15). It remains to be explored
further whether the extreme C-terminal region of ORC1 will
be responsible for origin DNA binding in eukaryotes.
During the asexual blood-stage P. falciparum developmental
cycle, PfORC1 is expressed during the ring stage, colocalizes
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with the P. falciparum replication foci marker proliferating cell
nuclear antigen (PfPCNA1) during the replicating-trophozoite
stage, and is degraded completely at the late schizont stage,
suggesting its regulatory role in Plasmodium DNA replication
(12). Interestingly, the presence of a putative PCNA-interact-
ing protein (PIP) motif in PfORC1 (residues 913 to 920) (see
Fig. 5A and see Fig. S1A in the supplemental material) further
supports the colocalization of PfORC1 and PCNA during
DNA replication. The putative PIP domain was identified in
different ORC1 homologs, including ScORC1, suggesting its
conserved yet unidentified role in DNA replication (12).
PCNA interacts with various proteins, like DNA polymerase,
Fen1, CDT1, MCM10, etc., with diverse roles ranging from
DNA replication to ubiquitination of various proteins leading
to their regulation (19).
The presence of a putative NTP-binding domain, a putative
PIP motif, and a unique extreme C-terminal region raises the
issue of whether these domains have any functional relevance
in PfORC1. It is extremely difficult to perform structure-func-
tion studies in Plasmodium due to the unavailability of a de-
pendable inducible gene expression system. This is due to the
time-consuming and poor transfection efficiency in P. falcipa-
rum. Moreover, an inducible gene expression system often
requires expression of the transgene (transactivator) and the
gene of interest under different promoters and use of different
selectable markers when used episomally, causing considerable
hindrance in regulation of gene expression. All of these exer-
cises also may result in leaky expression of the gene of interest
instead of tight regulation.
In order to dissect the functional domains of PfORC1, we
adopted a yeast genetic complementation approach along with
biochemical experiments. Earlier, genetic complementation
experiments in yeast were performed for detailed structure-
function analysis of P. falciparum proteins like dihydrofolate
reductase and histone-acetyltransferase GCN5 (9, 28). Using a
chimera approach for yeast genetic complementation, we
found that the putative NTP-binding domain, the PIP motif,
and the extreme C-terminal region of PfORC1 are truly func-
tional in the yeast heterologous system, suggesting their im-
portant role in DNA replication.
These findings offer a useful tool to study the structure and
function of essential proteins in P. falciparum that allows us to
identify novel functional domains in ORC1 with a conserved
role in DNA replication.
MATERIALS AND METHODS
Parasite culture. P. falciparum strain 3D7 was cultured in human O eryth-
rocytes in RPMI 1640 medium supplemented with 25 mM HEPES, 50 mg/liter
hypoxanthine, 0.2% NaHCO3, 0.5% Albumax (Invitrogen), 0.2% glucose, and 10
g/ml gentamicin sulfate. Synchronization of the cultures was achieved by 5%
sorbitol treatment.
ATP-binding assay. The ATP-binding assay was performed using 1 g of
maltose-binding protein (MBP)-PfORC1C wild-type or mutant protein following
the protocol described earlier (12). The proteins were cross-linked with
[-32P]ATP in the presence of UV light followed by precipitation of cross-linked
proteins by trichloroacetic acid. The pellet was further washed with acetone
containing 0.5% HCl and twice with acetone. Proteins were subjected to sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis, and
the radiolabeled ATP-bound protein was visualized using a PhosphorImager.
Complementation of yeast ORC1 mutant. Yeast complementation experi-
ments were performed using an S. cerevisiae ORC1 “swapper” strain (AIAy19) in
which the chromosomal copy of ORC1 has been deleted and a wild-type copy is
maintained in a yeast expression vector with a ura marker (a kind gift from Steve
Bell, MIT). This strain was used for complementation using either wild-type
ScORC1 or PfORC1 or different chimera constructs of S. cerevisiae and P.
falciparum ORC1. Details of the methods are described in the experimental
procedures part of the yeast complementation section in the supplemental ma-
terial.
DNA manipulation. Full-length or different domains of PfORC1 were ampli-
fied by PCR using P. falciparum 3D7 genomic DNA as template and specific
primers (see Table S1 in the supplemental material). Similarly, ScORC1 was
amplified using S. cerevisiae genomic DNA and specific primers (see Table S1 in
the supplemental material). For a detailed cloning strategy for the wild-type and
mutant forms of PfORC1 and ScORC1, see the supplemental material.
Recombinant protein purification. For the purification of PfORC1C fusion
proteins to perform the ATP-binding assay and electrophoretic mobility shift
assay (EMSA), the Escherichia coli BL21 Codon Plus strain was transformed
with respective recombinant clones. All recombinant proteins were MBP tagged
and purified by affinity chromatography using amylose resin. His6-tagged pro-
teins were purified using Ni-nitrilotriacetic acid (NTA) agarose beads (Qiagen).
Detailed methods for protein purification are described in the supplemental
material.
Gel shift assay. To investigate DNA binding activity of PfORC1C and other
proteins, reactions were carried out in a 20-l reaction volume containing DNA
binding buffer (10 mM Tris-Cl [pH 7.5], 100 mM KCl, 5 mM MgCl2, 2 mM
dithiothreitol, 6% glycerol, 50 g/ml bovine serum albumin). 30 ng of each
protein was incubated in DNA binding buffer containing the appropriate radio-
labeled [-32P]ATP DNA fragment (AT-rich probe, 242 bp, amplified from the
PfGyrA sequence using primer set P53 and P54; telomeric probe, 175 bp, am-
plified from chromosome 3 telomeric DNA sequence of P. falciparum using
primer set P51 and P52; and GC-rich probe, 242 bp, amplified from the tetr gene
of plasmid pBR322 using primer set P55 and P56) for 30 min at room temper-
ature. The samples were loaded on 5% native polyacrylamide gel, and the gel was
run at 150 V for 5 to 6 h at 4°C and then dried and autoradiographed.
RESULTS
Dissection of functional domains of PfORC1 in the yeast S.
cerevisiae. Based on the primary structure analysis, PfORC1
can be broadly divided into three domains. The N-terminal
region does not show any homology with ScORC1, and it
contains several repeat regions with asparagine and lysine res-
idues (domain I; amino acid residues 1 to 783) (Fig. 1A).
The middle domain of PfORC1 shows maximum homology
with ORC1 from different species. This domain (domain II;
amino acid residues 784 to 1014) contains the conserved nu-
cleotide binding and hydrolysis motif (residues 815 to 906) and
a putative PIP motif (residues 913 to 920) (Fig. 1A).
The extreme C-terminal domain of PfORC1 (domain III;
amino acid residues 1015 to 1189) exhibits very poor homology
with other ORC1 homologs (Fig. 1A).
It is important to find out whether domain II and domain III
have any important role in DNA replication in vivo. However,
it is difficult to address these questions in Plasmodium itself
due to the lack of a dependable inducible expression system.
Therefore, we adopted a yeast genetic complementation assay
to overcome these barriers.
Interestingly, cross-species complementation of ORC1 has
not been reported yet. We decided to perform functional
complementation in yeast using either full-length or deletion
mutants of PfORC1 or chimera constructs of ScORC1 and
PfORC1 fusing the N- and C-terminal regions of these respec-
tive proteins. We adopted the chimera approach due to the
presence of repeat regions at the N terminus of PfORC1 that
may affect the expression of full-length PfORC1 in yeast. Re-
cently, a similar chimera approach has worked for the comple-
mentation of an ORC5 mutant yeast strain using PfORC5 (12).
The N-terminal region of ScORC1 (ScORC1N; residues 1 to
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454) was fused with the C-terminal region of PfORC1
(PfORC1C; residues 694 to 1189), containing the homology
region and the extreme C-terminal region (domains II and III,
respectively) to get chimera I (Fig. 1A). While deciding on the
boundaries of different domains (I, II, and III) of ScORC1 and
PfORC1 for production of chimera constructs, we considered
various important features. These include the presence of a
suitable restriction enzyme site within the coding region (to
avoid creation of an extra restriction enzyme site during fu-
sion) and the secondary structure of both PfORC1 and
ScORC1 so that we do not delete helix or -sheet regions of
these proteins. These points are described in detail in the
Materials and Methods section of the supplemental material.
We also made chimera constructs in which the extreme C-
terminal region (domain III) of PfORC1C was deleted (chi-
mera II) or the extreme C-terminal region of PfORC1 (domain
III) was replaced with the same region from ScORC1 (chimera
III). An ORC1 mutant haploid strain of S. cerevisiae (AIAy19,
with the S. cerevisiae W303 background; a kind gift from Steve
Bell, MIT) (3) with a deletion of chromosomal copy of ORC1
and having the wild-type ORC1 gene in a plasmid containing a
ura3 marker was used for complementation studies. This yeast
strain was transformed with plasmid constructs containing var-
ious DNA fragments (as shown in Fig. 1A and B) or pRS314
empty vector under a galactose-inducible promoter with a tryp-
tophan marker. Following transformation, the transformants
were grown either in the absence or presence of 5-fluoroorotic
acid (5-FOA) for the selection of viable yeast cells in minimal
media without tryptophan. We find that full-length ScORC1
complements this mutant yeast strain in the presence of
5-FOA, whereas full-length PfORC1 cannot rescue these cells
under the same experimental conditions (Fig. 1B). Interest-
ingly, chimera I complements these cells, whereas only the
N-terminus region of ScORC1 or the empty vector pRS314
cannot rescue these cells (Fig. 1B). Similarly, PfORC1C can-
not complement the yeast ORC1 mutant strain (data not
shown). Surprisingly, we find that chimera II excluding domain
III of PfORC1C cannot complement the yeast strain, although
chimera III (in which domain III of PfORC1C has been re-
placed with the same region from ScORC1C) can complement
FIG. 1. Complementation of PfORC1 in the S. cerevisiae ORC1 swapper strain. (A) Schematic diagrams of PfORC1, ScORC1, and different
chimera constructs of the above two proteins. PfORC1 and ScORC1 can be divided into three parts: the N-terminal regulatory domain (I), the
conserved middle domain (II), and the extreme C-terminal domain (III). The black box shows the homology region. In chimera constructs, the gray
box shows the ScORC1 region and the open box shows the PfORC1 region. The rationale for chimera construction has been described in the
Results section and in the Materials and Methods section in the supplemental material. (B) The S. cerevisiae ORC1 swapper strain was transformed
with the constructs shown in panel A, and the growth of these transformed yeast cells was followed by spot test using serial dilutions in either Trp
FOA- or Trp FOA-containing plates. Only ScORC1, chimera I, and chimera III constructs rescued the growth of the mutant yeast strain in
the presence of FOA as a selection marker. Control pRS314 vector did not support genetic complementation under the same experimental
conditions. Wt, wild type.
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the mutant yeast strain. These results suggest that the extreme
C-terminal region of ORC1 plays a conserved role in DNA
replication, although it does not show homology at the amino
acid sequence level.
In order to confirm that the chimera I construct is indeed
responsible for complementation of the ORC1 mutant strain,
we performed reverse transcription-PCR (RT-PCR) analysis
using cDNA derived from either ScORC1 or the chimera I-
complemented strains using primers specific for ScORC1 or
the chimera I template. The ScORC1-specific primer sets could
yield PCR products from ScORC1 template, and the chimera
I-specific primers could amplify from the chimera I template
only (see Fig. S2A in the supplemental material), suggesting
that chimera I was indeed expressed at the mRNA level. The
RT-PCRs using control GAPDH (glyceraldehyde-3-phosphate
dehydrogenase) primers show the presence of these transcripts
in both samples (see Fig. S2B in the supplemental material).
The inability of PfORC1 to complement the yeast mutant
strain may reflect the presence of repeat regions at the N
terminus affecting the expression of full-length protein in yeast.
Many open reading frames in P. falciparum contain several
asparagines and lysine and serine-rich repeat regions (26). The
heterologous expression of Plasmodium proteins is extremely
difficult due to the 80% AT richness of the Plasmodium
genome and different codon usage in Plasmodium.
In order to investigate the expression level of PfORC1 in
yeast at both the mRNA level and the protein level, we per-
formed semiquantitative RT-PCR (as explained in Materials
and Methods) and Western blot analysis, respectively. Follow-
ing semiquantitative RT-PCR experiments, we find that the
expression of PfORC1 is only 10% at the transcript level
compared to ScORC1 expression, while chimera I is expressed
moderately (50%) (see Fig. S2C and D in the supplemental
material). The expression of control GAPDH transcript is
found to be similar in all cases (see Fig. S2C, bottom panel, in
the supplemental material). The expression of chimera I pro-
tein can be detected from yeast lysate obtained from chimera
I-transformed yeast cells using anti-PfORC1 polyclonal anti-
bodies, while full-length PfORC1 expression cannot be de-
tected under the same experimental conditions (see Fig. S2E,
upper panel, in the supplemental material). The Coomassie-
stained gel following protein transfer on membrane shows the
equal loading in both lanes (see Fig. S2E, lower panel, in the
supplemental material). These results establish that the inabil-
ity of full-length PfORC1 to complement the yeast ORC1
swapper strain is probably due to very weak or no expression of
full-length PfORC1 in yeast.
The nonconserved extreme C-terminal region of PfORC1
(domain III) is required for DNA binding. It has been shown
earlier that the extreme C-terminal region of ORC1/CDC6
contains a wing-helix region that is important for DNA binding
(6). We wanted to know whether the extreme C-terminal re-
gion of PfORC1 would show DNA-binding activity, which is
central to DNA replication.
For this purpose, we purified recombinant PfORC1C
(amino acid residues 689 to 1189) as an MBP fusion protein
either with the extreme C-terminal region (domain III) or
excluding that region (PfORC1C Tr) (residues 689 to 1022)
(Fig. 2A and B). We also purified a series of recombinant
proteins as controls for DNA binding experiments. We purified
an unrelated protein, MBP-RINGO (78 kDa), that stimu-
lates in vitro activity of PfPK5 kinase (18). We also expressed
and purified the extreme C-terminal region of PfORC1
(PfORC1C1; residues 1022 to 1189) and the N-terminal region
of PfORC1 (PfORC1N; residues 1 to 182) as MBP fusion
proteins (Fig. 2B). The estimated molecular masses of
PfORC1C, PfORC1C Tr, PfORC1C1, and PfORC1N are 83
kDa, 76 kDa, 59 kDa, and 61 kDa, respectively. Alone, MBP
(50 kDa) was purified as a control. These proteins migrate in
SDS-PAGE, inconsistently with their deduced molecular mass,
except for PfORC1N, which migrates higher than the esti-
mated molecular mass (Fig. 2B). This may be due to an inher-
ent property of this protein that contains leucine heptad re-
peats. We performed a gel mobility shift assay using these
proteins and a region (242 bp) from pBR322 DNA as a radio-
labeled probe. We found that a population of labeled DNA
was retarded significantly with increasing quantity of MBP-
PfORC1C protein compared to the free probe without the
addition of the protein (Fig. 2C). Interestingly, PfORC1C Tr
protein did not show any such shift. MBP-RINGO (with a
similar molecular mass to PfORC1C) and MBP alone also do
not show any shift (Fig. 2C) suggesting that the extreme C-
terminal region (domain III) of PfORC1 contains DNA-bind-
ing activity. However, this domain (PfORC1C1, domain III)
alone does not confer DNA binding, suggesting that additional
further upstream regions will be required for DNA binding
(Fig. 2C). Interestingly, the N-terminal region of PfORC1
(PfORC1N; 1 to 182 residues) does not show any DNA-bind-
ing activity under the same experimental conditions (data not
shown). Expression and purification of a longer polypeptide
from the N terminus of PfORC1 will be required to determine
specifically whether the N terminus of PfORC1 has any role in
DNA binding. The presence of several asparagines and lysine
repeat regions at the N terminus of PfORC1 affects the ex-
pression of this region in E. coli.
It has been shown recently that endogenous PfORC1 has
affinity toward the telomeric region and telomere-associated
repetitive elements (16). To find whether recombinant
PfORC1C has affinity toward the telomeric region, we have
performed a gel shift assay using radiolabeled probe containing
the telomeric region, as described earlier (16). We find that the
PfORC1C binds strongly to these regions, whereas PfORC1C
Tr does not bind under the same experimental conditions (see
Fig. S3A in the supplemental material).
In order to investigate whether the endogenous ORC has
affinity toward telomere-specific radiolabeled probe, we per-
formed a gel shift assay using P. falciparum nuclear extract. We
found a specific band shift in the presence of the nuclear
extract (see Fig. S3B in the supplemental material). These
band shifts show supershift in the presence of anti-PfORC1
antibodies but not in the presence of preimmune sera, suggest-
ing that these band shifts are specific for PfORC1 protein (see
Fig. S3B in the supplemental material). We have recently
shown that PfORC5, another member of the PfORC family,
colocalizes with PfORC1 in the trophozoite stage. To investi-
gate whether these band shifts are due to the presence of
PfORC as a complex, we performed a supershift assay using
anti-PfORC5 antibodies and preimmune sera. We found sim-
ilar supershifted bands in the presence of anti-PfORC5 anti-
bodies only (see Fig. S3B in the supplemental material). These
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findings suggest that the endogenous ORC as a complex has
affinity toward the telomeric region.
To investigate whether ATP stimulates the DNA-binding
activity of PfORC1C, we performed gel mobility shift assays
with various concentrations of ATP or AMPPNP (5-adenylyl-
,-imidodiphosphate), a nonhydrolyzable analog of ATP. We
found that neither ATP nor AMPPNP has a significant effect
on the DNA-binding activity of PfORC1C (Fig. 2D). Since the
FIG. 2. DNA-binding activity of PfORC1 and other deletion constructs by EMSA. (A) Schematic diagrams of PfORC1 and different deletion
mutants with amino acid coordinates are shown. The black box in PfORC1 indicates the maximum homology region with ScORC1 containing the
ATPase domain (domain II). (B) The Coomassie gel shows different MBP fusion proteins used in the EMSA. MBP alone, RINGO, and N-terminal
PfORC1N were used as controls. Asterisks indicate the major bands showing the purified protein. Lane M, molecular mass markers. (C) EMSA
was performed using the proteins described above in the presence of radiolabeled AT-rich probe. Only wild-type (Wt) PfORC1C shows strong
DNA-binding activity (lanes 1 to 8). The asterisk shows the protein-DNA complex compared to the free probe. (D) DNA-binding activity of
PfORC1C does not depend on ATP hydrolysis. EMSA was performed in the absence or presence of different quantities of ATP or AMPPNP (a
nonhydrolyzable analog of ATP) (lanes 1 to 8). The presence or absence of these nucleotides does not show any significant change in DNA-binding
activity of PfORC1C. PfORC1C has affinity toward AT-rich DNA since competition by GC-rich cold DNA does not alter PfORC1C DNA-binding
activity efficiently, whereas the cold AT-rich DNA shows significant competition even at a 1	 concentration (lanes 9 to 14).
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Plasmodium genome is 80% AT rich, it is logical to assume
that PfORC1C might have bias toward the AT-rich DNA.
Accordingly, we performed the gel mobility shift assay in the
presence of different quantities of cold AT-rich or GC-rich
DNA of similar sizes as the radiolabeled probe. The results
indicate that the cold GC-rich DNA does not affect the DNA
binding affinity of PfORC1C toward the radiolabeled probe
significantly, whereas the cold AT-rich competitor DNA can
abrogate the DNA binding very efficiently (Fig. 2D), suggesting
that PfORC1C indeed has a strong bias for AT-rich DNA.
The putative ATP-binding motif present in domain II of
PfORC1C is essential for ATP binding in vitro and viability in
yeast. The establishment of a functional complementation as-
say in a yeast orc1 mutant strain using PfORC1 (domains II
and III) allowed us further to dissect the role of the putative
ATPase domain present in domain II of PfORC1 (Fig. 3A). It
had been shown earlier that this domain is important for cell
viability in yeast. In vitro, ScORC binding to yeast ARS con-
sensus sequences is dependent on the presence of Walker A
and B motifs. Although we have reported earlier the ATPase
activity of recombinant PfORC1C, the functional significance
of this motif has not been characterized in vivo.
To address the issue of functional significance of the putative
Walker A motif present in PfORC1C (domain II), we first inves-
tigated the ATP-binding activity of PfORC1C in vitro. For this
purpose, wild-type PfORC1C and a mutant form of the protein
(with a point mutation of K to A in the Walker A domain) were
purified as recombinant MBP fusion proteins (Fig. 3A and B).
We found that PfORC1C wild-type protein binds to radiolabeled
[-32P]ATP, whereas the mutant protein fails to do so, suggesting
that the putative Walker A motif is functionally active (Fig. 3B,
lower panel).
The in vitro ATP-binding assay gave us the confidence to
test the functional significance of the putative NTP-binding
FIG. 3. The putative NTP-binding motif of PfORC1 is active both in vitro and in the heterologous yeast system. (A) Schematic diagram of the
chimera I construct (with the N terminus of ScORC1 and the C terminus of PfORC1) showing the wild-type (Wt) or mutant (Mut) form of the
NTP-binding domain in the inset box. Asterisks show the mutated residues. (B) ATP-binding assay. One microgram each of MBP-PfORC1CWt or
MBP-PfORC1CMut proteins was incubated with [-32P]dATP, and the mixture was further cross-linked using UV light as described in Materials and
methods. The upper panel shows the SDS-PAGE analysis of these UV cross-linked proteins. The molecular mass markers (M) are shown on the left.
The bottom panel shows the autoradiogram of the above gel. The arrowhead shows the position of the protein. (C) Genetic complementation assay with
chimera I wild-type or mutant constructs in the yeast ORC1 swapper strain as described above in the absence or presence of FOA. Only the wild type
(Wt), not the mutant (Mut) chimera I construct, could complement the mutant yeast strain in the presence of FOA selection.
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domain of PfORC1 in vivo. Accordingly, we made a point
mutation in the Walker A domain in the chimera I construct
and performed the yeast complementation experiments using
either the wild-type or mutant form of the chimera I construct.
We found that both constructs grow well in minimal media
lacking Trp (Trp), but only the wild-type chimera I and not
the mutant form can grow in the presence of 5-FOA (Fig. 3C).
These results suggest that the putative Walker A domain
present in PfORC1C is indeed important for in vivo function
and viability.
The putative PIP domain present in yeast and Plasmodium
ORC1 (domain II) plays a conserved role in cell viability.
PCNA is a master regulator of DNA replication and repair pro-
cesses that involve the direct physical interaction of PCNA with
several proteins that include but are not limited to Fen1, DNA
polymerase, and MCM10 (19). We discovered earlier the putative
PIP motif in PfORC1 and ScORC1 (12). We have also shown
that the in vitro interaction between PfORC1 and PfPCNA is
dependent on the putative PIP motif (12). Although, it is very
encouraging to see the direct in vitro interaction between
PfPCNA1 and PfORC1, there is no evidence of an in vivo phys-
ical interaction between these proteins in P. falciparum.
To address the issue described above, we performed a co-
immunoprecipitation experiment using anti-PfORC1 antibod-
ies from the replicating-trophozoite-stage parasite lysate
(obtained following DNase I treatment of the parasite nuclei
as described in Materials and Methods) followed by Western
blot analysis using anti-ORC1 and anti-PCNA antibodies. Both
anti-PfORC1 and anti-PfPCNA antibodies could recognize the
respective proteins in the parasite lysate following Western
blot analysis, whereas the preimmune sera failed to recognize
any such band under the same experimental conditions, sug-
gesting the specificity of these antibodies (Fig. 4A and B).
Following coimmunoprecipitation experiments, we found that
anti-ORC1 antibodies can pull down PfORC1 as well as
PfPCNA from replicating-trophozoite-stage parasite lysate,
whereas preimmune sera fail to do so under the same experi-
mental conditions (Fig. 4C), suggesting that both PfORC1 and
PfPCNA are truly in a complex in P. falciparum during active
DNA replication. This is consistent with our previously pub-
lished results showing interaction of another ORC subunit,
PfORC5, with PfPCNA by coimmunoprecipitation experi-
ments during the replicative-trophozoite stage (12). A recip-
rocal coimmunoprecipitation experiment using anti-PfPCNA
antibodies for immunoprecipitation and anti-PfORC1 antibod-
ies for immunoblotting was not conclusive (data not shown). It
may be due to the poor efficiency of anti-PfPCNA antibodies to
pull down the PCNA-ORC1 complex from the trophozoite-
stage parasite lysate.
To further confirm the coimmunoprecipitation results, we
performed immunocolocalization experiments using anti-
ORC1 and anti-PCNA antibodies during the replicating-tro-
phozoite stage and nonreplicating-late-schizont stage. We
found that both PfORC1 and PfPCNA show a punctate stain-
ing pattern representing replication foci during the trophozoite
stage, as described earlier (Fig. 4D) (12). Interestingly, both
PfORC1 and PfPCNA foci mostly colocalize with each other
during the replicating-trophozoite stage, confirming coimmu-
noprecipitation data as described above (Fig. 4D, rows 1 to 3).
During the late multinucleus schizont stage (in which the in-
dividual nuclei have separated from each other following DNA
replication) (Fig. 4D, rows 4 and 5), although bright PfPCNA
signals are still visible, the PfORC1 signal is very weak and no
distinct colocalization pattern between these proteins can be
detected, in contrast to the trophozoite stage. This is also
consistent with our previously published results, in which we
have shown that PfORC1 is completely degraded during the
late schizont stage (12). The colocalization pattern of PfORC1
and PfPCNA during the replicating-trophozoite stage in par-
asites truly reflects their presence in a complex.
To investigate whether the putative PIP domain in PfORC1C
has any functional significance, we used yeast complementation
experiments.
In order to find out first whether the putative PIP domain in
ScORC1 is truly required for DNA replication and cell viabil-
ity, we made a PIP domain mutant ScORC1 construct in which
all of the conserved residues (in boldface) were changed to
alanine (QDIMYNFF to ADIAYNAA) (Fig. 5A). We found
that this mutant ScORC1 cannot complement the ScORC1
mutant strain, whereas the wild-type ScORC1 complements
the mutant yeast strain efficiently (Fig. 5B). These results
strongly suggest that the PIP domain in yeast is essential for its
viability.
To further confirm our results, two conserved residues (the
extreme Q and F residues) present in the putative PfORC1
PIP domain (QKVLFTLF) were mutated to alanine in the
wild-type chimera I construct (Fig. 5A). The yeast ORC1 mu-
tant strain was transformed using the wild-type chimera I or
the mutant form along with the wild-type ScORC1 as a positive
control and either the N terminus of ScORC1 or the C termi-
nus of PfORC1 as a negative control. We found that the
wild-type chimera I construct can complement the yeast ORC1
mutant strain. However, the PIP mutant form fails to comple-
ment the yeast strain (Fig. 5B), suggesting the importance of
the PIP domain in cell viability and eukaryotic DNA replica-
tion in general.
In order to find out whether the mutation in the PIP
domain affects the direct interaction between PfORC1 and
PfPCNA1, we performed pull-down experiments using
MBP-tagged PfORC1C (wild type) or the mutant form of
the protein (PfORC1CPIPMut) along with MBP as control
protein in the presence of His6-tagged PfPCNA1 (Fig. 5C).
Pull-down experiments followed by Western blot analysis
using anti-PfPCNA1 antibodies show that only wild-type
PfORC1C, but not the mutant form nor MBP alone, can
bind to PfPCNA1 (Fig. 5C), suggesting a direct interaction
between ORC1 and PCNA1 through the PIP domain that
may be required for cell viability and DNA replication. The
Coomassie-stained gel (Fig., 5C, bottom panel) shows sim-
ilar loading of wild-type and mutant forms of PfORC1C and
the MBP control protein. Pull-down experiments were re-
peated several times, and similar results were obtained, as
shown from another set of experiments in Fig. S3C in the
supplemental material.
Furthermore, to validate whether the interaction between
ORC1 and PCNA also occurs between the yeast counterparts, we
have purified a carboxyl-terminal domain of ScORC1 (residues
401 to 780; ScORC1C) with either the wild-type or mutant PIP
motif (ScORC1CPIPMut) as MBP fusion proteins along with
ScPCNA as the His6-tagged protein (data not shown). Pull-down
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experiments as described above followed by Western blot analysis
using anti-His antibodies clearly indicate that ScPCNA binds
to ScORC1C wild-type protein with stronger affinity than
ScORC1PIPMut under the same experimental conditions (Fig.
5D), suggesting the importance of the PIP domain for the direct
physical interaction between ScORC1 and ScPCNA. The Coom-
assie-stained gel (Fig. 5D, bottom panel) shows the equal loading
of both proteins.
FIG. 4. Interaction between PfORC1 and PfPCNA1. (A) Western blot analysis of P. falciparum lysate using anti-PfORC1 antibodies detects
a specific band corresponding to PfORC1. Preimmune sera do not recognize any such band. Molecular mass markers (M) are shown on the left.
(B) Anti-PfPCNA1 antibodies but not the preimmune sera detect a specific band corresponding to PfPCNA1. (C) Coimmunoprecipitation of
PfPCNA1 and PfORC1. DNase I-treated lysate obtained from the replicating-trophozoite-stage parasite was immunoprecipitated (IP) using
anti-PfORC1 antibodies followed by immunoblotting (IB) using anti-ORC1 and anti-PfPCNA1 antibodies. Both PfORC1 and PfPCNA1 can be
coimmunoprecipitated using specific anti-PfORC1 antisera, but not with preimmune sera. Input lanes are shown on the left. (D) Colocalization
of PfPCNA1 and PfORC1 during the replicating-trophozoite stage. A glass slide containing a parasite smear from the replicating-trophozoite stage
or schizont stage was treated for immunofluoresence studies as described in Materials and Methods using both anti-PfORC1 and anti-PfPCNA1
antibodies. Distinct colocalization of PfORC1 and PfPCNA1 foci can be detected during the replicating-trophozoite stage (Troph.; rows 1 to 3).
Although the expression of PfPCNA can be detected at the multinucleated late schizont stage (rows 4 and 5), the expression of PfORC1 is barely
visible as the protein is degraded at the late stage, as described earlier. DAPI (4,6-diamidino-2-phenylindole) (I) shows the nuclei. Column IV
represents merged panels I, II, and III.
1348 GUPTA ET AL. EUKARYOT. CELL
 o
n
 N
ovem
ber 22, 2016 by guest
http://ec.asm
.org/
D
ow
nloaded from
 
The conserved Walker B ATP hydrolysis domain of PfORC1
resides within residues 903 to 906, and the putative PIP motif
resides within residues 913 to 920. To test whether the prox-
imity of these domains affects the ATP hydrolysis function of
PfORC1 due to the mutation in the PIP domain, we purified
the PfORC1C wild type and PfORC1CPIP mutant and per-
formed ATP hydrolysis assay along with an ATP-binding mu-
tant form of PfORC1C (17) and MBP as control proteins (as
described in the Materials and Methods section in the supple-
mental material). We found that MBP and the PfORC1C
FIG. 5. Role of the PIP domain in cell viability and interaction with PCNA. (A) Schematic diagrams of wild-type (Wt) ScORC1, PfORC1,
chimera I, and their different mutant (Mut) forms (as indicated on the right). The sequence and amino acid coordinates for the PIP box are shown.
Asterisks show the residues mutated for the study. (B) Yeast complementation assay to show the PIP domain is essential for yeast as well as
chimera proteins. The yeast ORC1 swapper strain was transformed with the constructs described above, and the viability of the yeast cells was
tested following a spot test after serial dilution in the absence (FOA) or presence (FOA) of FOA selection. The results indicate that the
wild-type PIP box is important for survival for ScORC1 as well as chimera I construct. (C) Pull-down experiments using beads containing the
wild-type or PIP mutant form of MBP-PfORC1C or the MBP control proteins in the presence of His6-PfPCNA as described in Materials and
Methods. Western blot analysis using anti-PfPCNA antibodies shows the specific binding of wild-type PfORC1C with PfPCNA. The bottom panel
shows the Coomassie-stained gel following protein transfer as a loading control. The arrowheads show the purified MBP fusion proteins (top) or
MBP alone. (D) Pull-down experiments using yeast proteins. The pull-down experiments were performed using soluble His6-ScPCNA protein and
the wild-type or PIP mutant form of MBP-ScORC1C protein bound on beads as described above for Plasmodium proteins followed by Western
blot analysis using anti-His polyclonal antibodies. The results indicate the strong affinity of ScPCNA toward the wild-type ScORC1C compared to
the mutant form of the protein. The bottom panel shows the Coomassie-stained gel following protein transfer, and the arrowhead indicates the
position of the respective proteins. (E) ATPase activity of different proteins. The ATPase assay was performed as described in Materials and
Methods using the wild-type or PIP mutant form of MBP-PfORC1C or MBP-PfORC1C (ATPase mutant) or MBP, and the relative ATPase
activity of each protein was plotted accordingly. The results indicate that the activities of the wild-type and PIP mutant forms of PfORC1C do not
differ significantly.
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ATP-binding mutant do not show significant ATPase activity,
whereas both PfORC1C wild-type and the PfORC1CPIP mu-
tant proteins show similar ATPase activity, suggesting that
mutation in PIP domain does not affect the catalytic activity of
PfORC1 significantly (Fig. 5E). These results suggest that the
inability of chimera I PIP mutant construct to complement the
yeast ORC1 swapper strain is most likely because of the defect
in interaction between these proteins and is not due to the
effect on the ATPase activity.
DISCUSSION
The presence of the PIP motif in ORC1 homologs is an
important finding (12). Here we show that the mutation in the
PIP motif of ScORC1 leads to the loss of viability of yeast cells,
suggesting its essential role in DNA replication. Similarly, the
non-viability of the PIP mutant form of chimera I-transformed
ScORC1 mutant cells confirms that the PIP domain is con-
served and functional across the species. The direct interaction
between PfPCNA1 and wild-type PfORC1C but not the PIP
mutant protein clearly indicates that the PIP motif is truly
important for this interaction. These findings set the platform
to explore the biological significance of the ORC-PCNA inter-
action in vivo. We think that ORC foci do not represent the
ORC proteins participating in pre-RCs only but rather ORC
proteins that bind to PCNA directly via the PIP box at the
replication foci. This is consistent with our previously pub-
lished results showing the reduction of ORC foci in the pres-
ence of hydroxyurea, a known replication inhibitor (12). Per-
haps the loss of ORC1 (which contains the PIP box) at the late
schizont stage explains why the overlap between PfORC5 and
PCNA also seems to decline later in the S phase (12).
Alternatively, it remains to be explored further whether the
PIP domain in PfORC1 is responsible for the SCF-skp2-cul4-
dependent degradation of PfORC1 at the later stages, as has
been shown for cdt1, another important replication initiation
protein conserved in higher eukaryotes (1, 20, 25).
We find that the PIP domain is important for cell survival in
yeast and Plasmodium. Since there is a basic difference in
multiple rounds of rapid DNA replication during the blood
stage in Plasmodium compared to the single round of DNA
replication in the yeast cell cycle, the mechanism and the
extent by which PIP domain will modulate PCNA and ORC
function in different organisms may differ significantly.
The PfPCNA foci obtained during the late schizont stage
may explain its involvement in repair processes like translesion
synthesis, as reported earlier in mammalian cells (7, 8, 19). The
presence of PCNA at the late stages may also be required for
ubiquitination-dependent degradation of CDT1 like licensing
factors in Plasmodium, important for the control of DNA rep-
lication (1). Interestingly, a putative CDT1 homolog has been
found in P. falciparum recently (S. K. Dhar and A. Pietro,
unpublished data).
The conserved function of the extreme C-terminal region of
ORC1 with little or no sequence homology is also a novel
finding. It has been reported that the archaeal CDC6/ORC1
like protein primarily binds to origin DNA through the wing-
helix domain present at the extreme C-terminal region of these
proteins (10). It is important to note that unlike higher eu-
karyotes, archaea contain defined replication origins where
initiation takes place. S. cerevisiae ORC binds to ARS consen-
sus sequence in a sequence-specific manner in an ATP-depen-
dent fashion. Homo sapiens ORC (HsORC) and D. melano-
gaster ORC (DmORC) also bind to DNA as a complex, and
there has been no report so far that an individual ORC subunit
may bind to DNA in these systems. Binding of PfORC1 to
DNA like archaeal ORC1/CDC6 protein may suggest that
Plasmodium ORC1 is closer to the archaeal counterpart. In
fact, phylogenetic analysis of C-terminal region of PfORC1
with other ORC1 homologs shows that it is closer to archaeal
CDC6/ORC1 (data not shown). Surprisingly, Plasmodium also
does not contain a separate CDC6 like molecule like archaea
and it contains fewer ORCs like ORC5 and possibly an ORC2
homolog. The DNA binding capability of PfORC1 thus may
become important and significant due to the presence of sim-
pler ORC with fewer components in Plasmodium.
The secondary structure analysis of the extreme-C-terminal
region of PfORC1C reveals the presence of a helix-turn-helix
domain similar to that has been reported in yeast, human, and
archaeal CDC6/ORC1 proteins (data not shown) (6). Together
with the in vitro DNA-binding activity of the C-terminal region
of PfORC1 and the presence of the helix-turn-helix domain at
the extreme C-terminal region of PfORC1, in vivo complemen-
tation results convincingly establish a global conserved role of
this domain between highly divergent species.
It is evident from the in vitro ATP-binding assay and in vivo
complementation assay that the putative NTP-binding domain
in PfORC1 is functional. PfORC1 shows ATP-independent
DNA-binding activity, contrary to S. cerevisiae ORC, whose
DNA-binding activity is dependent on ATP binding and hy-
drolysis. PfORC1 may show nonspecific ATP-independent
DNA binding in vitro, whereas ATP may play a major role in
binding active origins in vivo. The in vivo complementation of
the ScORC1 mutant strain with the chimera I construct con-
taining the NTP-binding domain supports this hypothesis.
Does ORC1 play similar role in other protozoan parasites?
Recently, an ORC1 homolog has been reported in the kineto-
plastid Leishmania major that codes for a much smaller ORC1
protein (434 amino acid residues) than PfORC1 (1,189
amino acid residues) (13). L. major contains only one ORC
subunit with a conserved ATPase domain. Immunofluores-
cence analysis of the green fluorescent protein-L. major ORC1
(LmORC1)-expressing parasite line shows constitutive nuclear
expression of LmORC1 throughout the cell cycle. This is con-
trary to the regulated expression of PfORC1 during the asexual
blood-stage cycle. However, this study does not describe the
fate of the endogenous protein due to the non-availability of
anti-ORC1 antibodies.
In this study, we have used yeast genetic complementation
and biochemical experiments to study essential gene function
in Plasmodium. We find these techniques very useful to dissect
PfORC1 function in vivo and to identify previously undiscov-
ered unique features of ORC1 proteins.
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